Sarcoidosis incidence and prevalence: A nationwide register-based assessment in Sweden

European Respiratory Journal

Volumn 48, Issue 6, 2016, Pages 1690-1699

  Arkema, Elizabeth V ^a   Grunewald, Johan ^a,b   Kullberg, Susanna ^a,b   Eklund, Anders ^a,b   Askling, Johan ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DISEASE REGISTRY; EDUCATIONAL STATUS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SARCOIDOSIS; SEX DIFFERENCE; SWEDEN; SWEDISH CITIZEN; TREND STUDY; INCIDENCE; MIDDLE AGED; REGISTER; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; SARCOIDOSIS; SEX DISTRIBUTION; SWEDEN;

EID: 85006141251     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00477-2016     Document Type: Article

References (37)

1. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990; 7: 113-118.
2. Statement on Sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
3. Hillerdal G, Nou E, Osterman K, et al. Sarcoidosis: Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984; 130: 29-32.
4. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-241.
5. Erdal BS, Clymer BD, Yildiz VO, et al. Unexpectedly high prevalence of sarcoidosis in a representative U.S. Metropolitan population. Respir Med 2012; 106: 893-899.
6. Henke CE, Henke G, Elveback LR, et al. The epidemiology of sarcoidosis in Rochester, Minnesota: A population-based study of incidence and survival. Am J Epidemiol 1986; 123: 840-845.
7. Parkes SA, Baker SB, Bourdillon RE, et al. Incidence of sarcoidosis in the Isle of Man. Thorax 1985; 40: 284-287.
8. Gribbin J, Hubbard RB, Le Jeune I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-985.
9. Thomeer M, Demedts M, Vandeurzen K, et al. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg 2001; 56: 163-172.
10. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 46-52.
11. Deubelbeiss U, Gemperli A, Schindler C, et al. Prevalence of sarcoidosis in Switzerland is associated with environmental factors. Eur Respir J 2010; 35: 1088-1097.
12. Selroos O. The frequency, clinical picture and prognosis of pulmonary sarcoidosis in Finland. Acta Med Scand Suppl 1969; 503: 3-73.
13. Kowalska M, Niewiadomska E, Zejda JE. Epidemiology of sarcoidosis recorded in 2006-2010 in the Silesian voivodeship on the basis of routine medical reporting. Ann Agric Environ Med 2014; 21: 55-58.
14. Kim DS. Sarcoidosis in Korea: Report of the second nationwide survey. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 176-180.
15. Yamaguchi M, Hosoda Y, Sasaki R, et al. Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis 1989; 6: 138-146.
16. Reich JM. A critical analysis of sarcoidosis incidence assessment. Multidiscip Respir Med 2013; 8: 57.
17. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis 1990; 7: 50-57.
18. Anderzen-Carlsson A, Lamy ZC, Tingvall M, et al. Parental experiences of providing skin-To-skin care to their newborn infant - part 2: A qualitative meta-synthesis. Int J Qual Stud Health Well-Being 2014; 9: 24907.
19. Foreman MG, Mannino DM, Kamugisha L, et al. Hospitalization for patients with sarcoidosis: 1979-2000. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 124-129.
20. Sawahata M, Sugiyama Y, Nakamura Y, et al. Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan. Respir Med 2015; 109: 272-278.
21. Gillman A, Steinfort C. Sarcoidosis in Australia. Int Med J 2007; 37: 356-359.
22. Gerke AK, Yang M, Tang F, et al. Increased hospitalizations among sarcoidosis patients from 1998 to 2008: A population-based cohort study. BMC Pulm Med 2012; 12: 19.
23. Henke M, Engler H, Engelhardt R, et al. Successful therapy of sarcoidosis-Associated thrombocytopenia refractory to corticosteroids by a single course of human gammaglobulins. Klin Wochenschr 1986; 64: 1209-1211.
24. Grunewald J, Eklund A. Lofgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 2009; 179: 307-312.
25. Kreider ME, Christie JD, Thompson B, et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005; 128: 207-215.
26. Selroos O. Sarcoidosis and pregnancy: A review with results of a retrospective survey. J Intern Med 1990; 227: 221-224.
27. Cozier YC, Berman JS, Palmer JR, et al. Reproductive and hormonal factors in relation to incidence of sarcoidosis in us black women: The Black Women's Health Study. Am J Epidemiol 2012; 176: 635-641.
28. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170: 1324-1330.
29. Salmela E, Lappalainen T, Liu J, et al. Swedish population substructure revealed by genome-wide single nucleotide polymorphism data. Plos One 2011; 6: E16747.
30. Grunewald J, Spagnolo P, Wahlstrom J, et al. Immunogenetics of disease-causing inflammation in sarcoidosis. Clin Rev Allergy Immunol 2015; 49: 19-35.
31. Nilsson K, Pahlson C, Lukinius A, et al. Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis. J Infect Dis 2002; 185: 1128-1138.
32. Derler AM, Eisendle K, Baltaci M, et al. High prevalence of 'Borrelia-like' organisms in skin biopsies of sarcoidosis patients from Western Austria. J Cutan Pathol 2009; 36: 1262-1268.
33. Jaenson TG, Jaenson DG, Eisen L, et al. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasites Vectors 2012; 5: 8.
34. Cozier YC, Berman JS, Palmer JR, et al. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest 2011; 139: 144-150.
35. Cragin LA, Laney AS, Lohff CJ, et al. Use of insurance claims data to determine prevalence and confirm a cluster of sarcoidosis cases in Vermont. Public Health Rep 2009; 124: 442-446.
36. Dumas O, Abramovitz L, Wiley AS, et al. Epidemiology of sarcoidosis in a prospective cohort study of U.S. Women. Ann Am Thorac Soc 2016; 13: 67-71.
37. Gorham ED, Garland CF, Garland FC, et al. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in navy personnel: A 27-year historical prospective study, 1975-2001. Chest 2004; 126: 1431-1438.